Paul Mango, Warp Speed leader and Trump adviser, dies at 65
Mango was instrumental to the effort to develop Covid-19 vaccines and treatments, and was working on the Trump transition effort.
Related Articles
Netanyahu bevestigt akkoord, vandaag stemming veiligheidskabinet
De Israëlische premier stelde goedkeuring gisteren op het allerlaatste moment uit omdat Hamas nog extra eisen zou hebben, iets wat de terreurorganisatie ontkent.
Evaluating the accuracy of point prevalence surveys: a comparative analysis with Hungarian National Nosocomial Surveillance (NNSR) data
Nosocomial infections, or healthcare-associated infections, pose significant challenges to healthcare systems. According to the WHO, approximately 7% of hospitalized patients in developed countries and 10%…
How the FDA and CMS worked together on a new approach to paying for digital mental health treatments
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes to improve access to care.
An NYC nonprofit has reversed 1,700 overdoses since 2021. Under Trump, it faces an uncertain future
OnPoint NYC’s supervised consumption site offers lifesaving harm reduction services, reversing 1,700 overdoses since 2021, but faces political headwinds.
Trump nominees for health positions should fail the ‘Fauci test’
The Senate confirmation face-offs for key health roles will play out through powerful pandemic references. Here’s what to watch for.
BHIVA Spring Conference 2025
The BHIVA Spring Conference is moving to Brighton for 2025! We will as usual have a packed, relevant and high-quality scientific programme for attendees along…
Virtual care providers double down on GLP-1s, regulating health AI, and more JPM news
In the latest edition of STAT’s Health Tech newsletter: Health AI regulation challenges confronting the Trump administration, and more.
Episode 174: The H5N1 Pandemic Cliff: Are We at the Edge?
In “The H5N1 Pandemic Cliff: Are We at the Edge?,” Dr. Osterholm and Chris Dall discuss the ongoing challenge of H5N1 influenza, cover increasing trends…
The most essential and memorable JPM moments, recapped
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. We have made it!…
Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials
In hospitalised patients with severe influenza, oseltamivir and peramivir might reduce duration of hospitalisation compared with standard care or placebo, although the certainty of evidence…
